News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
316,907 Results
Type
Article (26116)
Company Profile (152)
Press Release (290639)
Section
Business (91258)
Career Advice (1294)
Deals (14142)
Drug Delivery (74)
Drug Development (38221)
Employer Resources (152)
FDA (7960)
Job Trends (8526)
News (153221)
Policy (13438)
Tag
Academia (1956)
Alliances (25004)
Alzheimer's disease (758)
Approvals (7914)
Artificial intelligence (93)
Bankruptcy (92)
Best Places to Work (7245)
Biotechnology (95)
Breast cancer (67)
Cancer (568)
Cardiovascular disease (62)
Career advice (1138)
Cell therapy (139)
Clinical research (30223)
Collaboration (265)
Compensation (75)
COVID-19 (1291)
C-suite (71)
Cystic fibrosis (67)
Data (706)
Diabetes (91)
Diagnostics (3231)
Earnings (25610)
Employer resources (133)
Events (47625)
Executive appointments (222)
FDA (8301)
Funding (222)
Gene therapy (124)
GLP-1 (348)
Government (2258)
Healthcare (9775)
Infectious disease (1343)
Inflammatory bowel disease (84)
Interviews (192)
IPO (6299)
Job creations (1564)
Job search strategy (1001)
Layoffs (169)
Legal (2158)
Lung cancer (87)
Manufacturing (109)
Medical device (6186)
Medtech (6190)
Mergers & acquisitions (7966)
Metabolic disorders (242)
Neuroscience (948)
NextGen Class of 2024 (3654)
Non-profit (3445)
Northern California (846)
Obesity (140)
Opinion (114)
People (32879)
Phase I (8683)
Phase II (13050)
Phase III (11220)
Pipeline (246)
Postmarket research (1234)
Preclinical (3825)
Press Release (61)
Radiopharmaceuticals (115)
Rare diseases (159)
Real estate (3183)
Recruiting (58)
Regulatory (9719)
Research institute (1719)
Resumes & cover letters (165)
Southern California (676)
Startups (2361)
United States (7355)
Vaccines (253)
Weight loss (103)
Date
Today (81)
Last 7 days (445)
Last 30 days (2064)
Last 365 days (20296)
2024 (18569)
2023 (22459)
2022 (27552)
2021 (30632)
2020 (28328)
2019 (25200)
2018 (18732)
2017 (16363)
2016 (15825)
2015 (17415)
2014 (12650)
2013 (10239)
2012 (10756)
2011 (11092)
2010 (10054)
Location
Africa (473)
Arizona (77)
Asia (18294)
Australia (3321)
California (1811)
Canada (604)
China (123)
Colorado (75)
Connecticut (95)
Europe (45293)
Florida (265)
Georgia (77)
Illinois (184)
Indiana (164)
Maryland (269)
Massachusetts (1434)
Michigan (88)
Minnesota (142)
New Jersey (605)
New York (563)
North Carolina (445)
Northern California (846)
Ohio (90)
Pennsylvania (409)
South America (625)
Southern California (676)
Texas (227)
Washington State (134)
316,907 Results for "endra life sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
November 15, 2024
·
10 min read
BioMidwest
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announced that it has priced a public offering with gross proceeds to the Company expected to be approximately $8.0 million, before deducting placement agent fees and other estimated expenses payable by the Company.
June 4, 2024
·
6 min read
BioMidwest
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announces the issuance of five new patents, including three in Europe and two in China.
May 2, 2024
·
5 min read
Business
ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months ended March 31, 2024 on Tuesday, May 14, 2024 after the close of trading on the U.S. financial markets.
May 7, 2024
·
2 min read
Press Releases
Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
November 13, 2024
·
4 min read
Business
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended March 31, 2024 and provided a business update.
May 14, 2024
·
10 min read
Press Releases
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
October 23, 2024
·
5 min read
Business
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
ENDRA Life Sciences Inc. today announced that the company will report financial results for the three months and year ended December 31, 2023 on Thursday, March 28, 2024 after the close of trading on the U.S. financial markets.
March 21, 2024
·
2 min read
Business
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and year ended December 31, 2023 and provides a business update.
March 28, 2024
·
11 min read
BioMidwest
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces the issuance of three new patents, including one in the U.S., one in China and one in Europe.
February 14, 2024
·
5 min read
1 of 31,691
Next
